Introducing a granule based protein substitute to the diet of a child with phenylketonuria to address reluctance to ingest phenylalanine-free protein substitute: A case report.

IF 1.9 Q3 NUTRITION & DIETETICS
Nutrition and health Pub Date : 2024-03-01 Epub Date: 2023-06-26 DOI:10.1177/02601060231184934
Camille Newby
{"title":"Introducing a granule based protein substitute to the diet of a child with phenylketonuria to address reluctance to ingest phenylalanine-free protein substitute: A case report.","authors":"Camille Newby","doi":"10.1177/02601060231184934","DOIUrl":null,"url":null,"abstract":"<p><p>Phenylalanine (Phe)-free protein substitutes are used within the management of phenylketonuria (PKU). However, adherence to the Phe-restricted diet is often challenging. A child (age 4.5 years) with PKU rejected the Phe-free protein substitutes used within her therapeutic diet, causing stress for herself and family at mealtimes. Switching to a new Phe-free protein substitute that can be mixed into other foods [PKU GOLIKE<sup>®</sup> (3-16)] provided an alternative strategy that was acceptable to the child. Good control of blood Phe was maintained. Newer Phe-free protein substitutes may provide a strategy for maintaining the therapeutic diet for PKU where the patient has difficulty doing so on standard substitutes. Here, the use of a Phe-free protein substitute with improved palatability and ease of use supported maintenance of the Phe-restricted diet for a child with PKU who struggled to maintain the diet on standard substitutes.</p>","PeriodicalId":19352,"journal":{"name":"Nutrition and health","volume":" ","pages":"35-38"},"PeriodicalIF":1.9000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10924697/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nutrition and health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/02601060231184934","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/26 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0

Abstract

Phenylalanine (Phe)-free protein substitutes are used within the management of phenylketonuria (PKU). However, adherence to the Phe-restricted diet is often challenging. A child (age 4.5 years) with PKU rejected the Phe-free protein substitutes used within her therapeutic diet, causing stress for herself and family at mealtimes. Switching to a new Phe-free protein substitute that can be mixed into other foods [PKU GOLIKE® (3-16)] provided an alternative strategy that was acceptable to the child. Good control of blood Phe was maintained. Newer Phe-free protein substitutes may provide a strategy for maintaining the therapeutic diet for PKU where the patient has difficulty doing so on standard substitutes. Here, the use of a Phe-free protein substitute with improved palatability and ease of use supported maintenance of the Phe-restricted diet for a child with PKU who struggled to maintain the diet on standard substitutes.

在苯丙酮尿症患儿的饮食中引入颗粒状蛋白质替代品,以解决不愿摄入不含苯丙氨酸的蛋白质替代品的问题:病例报告。
不含苯丙氨酸(Phe)的蛋白质替代品被用于治疗苯丙酮尿症(PKU)。然而,坚持限制 Phe 的饮食往往具有挑战性。一名患有 PKU 的儿童(4.5 岁)拒绝接受治疗饮食中使用的不含 Phe 的蛋白质替代品,这给她自己和家人的进餐带来了压力。改用可混入其他食物中的不含 Phe 的新型蛋白质替代品 [PKU GOLIKE® (3-16)],为孩子提供了一种可接受的替代策略。血 Phe 得到了良好的控制。不含 Phe 的新型蛋白质替代品可为患者提供一种策略,在患者难以使用标准替代品的情况下维持 PKU 的治疗饮食。在这里,使用不含 Phe 的蛋白质替代品,不仅改善了适口性,而且使用方便,有助于维持 PKU 患儿的 Phe 限制饮食,因为该患儿在使用标准替代品时很难维持饮食。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nutrition and health
Nutrition and health Medicine-Medicine (miscellaneous)
CiteScore
3.50
自引率
0.00%
发文量
160
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信